Huberman M - Search Results

1

A phase I study of an outpatient regimen of recombinant human interleukin-2 and alpha-2a-interferon in patients with solid tumors.

Huberman M, Bering H, Fallon B, Tessitore J, Sonnenborn H, Paul S, Zeffren J, Levitt D, Groopman J. Huberman M, et al. Cancer. 1991 Oct 15;68(8):1708-13. doi: 10.1002/1097-0142(19911015)68:8<1708::aid-cncr2820680810>3.0.co;2-v. Cancer. 1991. PMID: 1913512 Clinical Trial.

2

A phase I study of recombinant human interleukin-2 and alpha-interferon-2a in patients with renal cell cancer, colorectal cancer, and malignant melanoma.

Mittelman A, Huberman M, Puccio C, Fallon B, Tessitore J, Savona S, Eyre R, Gafney E, Wick M, Skelos A, et al. Mittelman A, et al. Among authors: huberman m. Cancer. 1990 Aug 15;66(4):664-9. doi: 10.1002/1097-0142(19900815)66:4<664::aid-cncr2820660411>3.0.co;2-d. Cancer. 1990. PMID: 2386896

3

5-Fluorouracil and alpha-interferon in hepatocellular carcinoma.

Stuart K, Tessitore J, Huberman M. Stuart K, et al. Among authors: huberman m. Am J Clin Oncol. 1996 Apr;19(2):136-9. doi: 10.1097/00000421-199604000-00009. Am J Clin Oncol. 1996. PMID: 8610636

4

A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinoma.

Sanz-Altamira PM, Ferrante K, Jenkins RL, Lewis WD, Huberman MS, Stuart KE. Sanz-Altamira PM, et al. Among authors: huberman ms. Cancer. 1998 Jun 15;82(12):2321-5. Cancer. 1998. PMID: 9635523 Clinical Trial.

5

Vinblastine plus cisplatin in advanced non-small cell lung cancer: lack of advantage for vinblastine infusion schedule.

Huberman M, Lokich J, Greene R, Paul S, Phillips D, Sonneborn H, Zipoli T. Huberman M, et al. Cancer Treat Rep. 1986 Feb;70(2):287-9. Cancer Treat Rep. 1986. PMID: 3004727

6

Etoposide in combination with cytarabine, doxorubicin, and 6-thioguanine for treatment of acute nonlymphoblastic leukemia in a protocol adjusted for age.

Bern MM, Wallach SR, Arkin CF, Lokich JJ, Huberman MS, Anderson NR, Corkery JC, Paul SD, Phillips DF, Sonneborn HA, et al. Bern MM, et al. Among authors: huberman ms. Cancer Treat Rep. 1987 Feb;71(2):201-3. Cancer Treat Rep. 1987. PMID: 3802115

7

Recombinant alpha 2 interferon-related cardiomyopathy.

Cohen MC, Huberman MS, Nesto RW. Cohen MC, et al. Among authors: huberman ms. Am J Med. 1988 Oct;85(4):549-51. doi: 10.1016/s0002-9343(88)80094-9. Am J Med. 1988. PMID: 3177405 No abstract available.

8

Phase 1-2a multicenter dose-ranging study of canfosfamide in combination with carboplatin and paclitaxel as first-line therapy for patients with advanced non-small cell lung cancer.

Sequist LV, Fidias PM, Temel JS, Kolevska T, Rabin MS, Boccia RV, Burris HA, Belt RJ, Huberman MS, Melnyk O, Mills GM, Englund CW, Caldwell DC, Keck JG, Meng L, Jones M, Brown GL, Edelman MJ, Lynch TJ. Sequist LV, et al. Among authors: huberman ms. J Thorac Oncol. 2009 Nov;4(11):1389-96. doi: 10.1097/JTO.0b013e3181b6b84b. J Thorac Oncol. 2009. PMID: 19701107 Free article. Clinical Trial.

9

Pooled analysis of the prospective trials of gefitinib monotherapy for EGFR-mutant non-small cell lung cancers.

Costa DB, Kobayashi S, Tenen DG, Huberman MS. Costa DB, et al. Lung Cancer. 2007 Oct;58(1):95-103. doi: 10.1016/j.lungcan.2007.05.017. Epub 2007 Jul 3. Lung Cancer. 2007. PMID: 17610986 Free PMC article.

10

Adriamycin, cyclophosphamide, and etoposide (VP-16-213) in extensive-stage small cell lung cancer.

Matelski HW, Lokich JJ, Huberman MS, Zipoli TE, Paul S, Sonneborn H, Philips D. Matelski HW, et al. Among authors: huberman ms. Am J Clin Oncol. 1984 Dec;7(6):729-32. doi: 10.1097/00000421-198412000-00024. Am J Clin Oncol. 1984. PMID: 6099053

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters